73812
Quantitation of glycated haemoglobin — as a point‑of‑care test; and (b) by or
Pathology services · Group P9 — Simple basic pathology tests
Schedule fee
$11.80
| Benefit | Amount | Gap to fee |
|---|---|---|
| 85% | $10.05 | $1.75 |
| 75% | $8.85 | $2.95 |
Benefit amounts as published in the schedule, not recalculated.
Fee current from 1 Nov 2021.
Conditions in the descriptor
3× per 12 months
Descriptor · the legislated text
Quantitation of glycated haemoglobin (HbA1c) performed in the management of established diabetes, if performed: (a) as a point‑of‑care test; and (b) by or on behalf of a medical practitioner who works in a general practice that is accredited to the Royal Australian College of General Practitioners Standards for point‑of-care testing under the National General Practice Accreditation Scheme; and (c) using a method certified by the National Glycohemoglobin Standardization Program (NGSP), if the instrumentation used has a total coefficient variation less than 3.0% at 48 mmol/mol (6.5%) Applicable not more than 3 times per 12 months per patient
Descriptor current from 1 Jul 2023.
Explanatory notes · departmental guidance · 1
PR.9.4 Limitation of item 73812
Note PR.9.4
Item 73812 does not apply to a service provided to a patient who has already been provided, in the last 12 months, 4 other services to which any of the following apply:
- item 73812;
- item 66551;
- item 73826.
| Item number | 73812 |
|---|---|
| Category | 6 — Pathology services |
| Group | P9 — Simple basic pathology tests |
| Subheading | — |
| Item type | S |
| Fee type | N |
| In schedule since | 1 Nov 2021 |
| Fee current from | 1 Nov 2021 |
| GP scope | Yes · tier 2 |
Official page
As at 1 Aug 2026